Longeveron LLC is a biotechnology business based in the US. Longeveron LLC shares (LGVN) are listed on the NASDAQ and all prices are listed in US Dollars.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $2.70 |
|---|---|
| 52-week range | $2.80 - $16.77 |
| 50-day moving average | $3.64 |
| 200-day moving average | $4.60 |
| Wall St. target price | $13.60 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.88 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.7 from 2023-03-20
| 1 week (2023-03-13) | -8.16% |
|---|---|
| 1 month (2023-02-18) | N/A |
| 3 months (2022-12-22) | -3.91% |
| 6 months (2022-09-22) | -31.99% |
| 1 year (2022-03-22) | -61.15% |
|---|---|
| 2 years (2021-03-22) | -62.81% |
| 3 years (2020-03-18) | N/A |
| 5 years (2018-03-18) | N/A |
| Revenue TTM | $1.2 million |
|---|---|
| Gross profit TTM | $497,000 |
| Return on assets TTM | -31.59% |
| Return on equity TTM | -65% |
| Profit margin | 0% |
| Book value | $0.98 |
| Market capitalisation | $60.4 million |
TTM: trailing 12 months
We're not expecting Longeveron LLC to pay a dividend over the next 12 months.
Longeveron LLC's shares were split on a 2:5 basis on 11 March 2008. So if you had owned 5 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Longeveron LLC shares – just the quantity. However, indirectly, the new 150% higher share price could have impacted the market appetite for Longeveron LLC shares which in turn could have impacted Longeveron LLC's share price.
Over the last 12 months, Longeveron LLC's shares have ranged in value from as little as $2.8 up to $16.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Longeveron LLC's is 0.7572. This would suggest that Longeveron LLC's shares are less volatile than average (for this exchange).
To put Longeveron LLC's beta into context you can compare it against those of similar companies.
Longeveron Inc. , a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida. .
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.